# Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

> **NCT00304408** · — · COMPLETED · sponsor: **Michael E. DeBakey VA Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Clostridium Enterocolitis
- Pseudomembranous Colitis
- Antibiotic-Associated Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00304408
- **Lead sponsor:** Michael E. DeBakey VA Medical Center
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304408, "Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00304408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*